What evidence, if any, concerns allergens or symptoms rather than microorganisms alone?

What evidence, if any, concerns allergens or symptoms rather than microorganisms alone?

The company publishes no allergen count and no symptom measurement.

The Validation page states that NanoFlashing™ is tested under Good Laboratory Practice to US EPA Health Effects Test Guidelines, and it names Product Safety Labs, Study 65321, Study 65322, Study 65323 and Study 65324. The Validation page also states that NanoFlashing™ is certified to OEKO-TEX® Standard 100, Product Class II, the class for products in direct contact with skin, and it names OEKO-TEX Service GmbH, Certificate 17.0.25812. NanoFlashing™ is passive. It generates no ozone, releases nothing, and adds nothing to what passes through. The Terms of Use state that a laboratory reduction in a virus, bacterium, fungus, particle, or other endpoint does not establish a clinical benefit, fewer infections, disease prevention or treatment, or improved health, and: “Do not use Site Content to diagnose, treat, or make a patient-care or infection-control decision.” The NanoFlashing™ Air Filter label states that the filter is not a medical device and is not intended to diagnose, treat, cure or prevent disease. The Validation page lists the organisms tested, and a result does not carry across to an organism its own test did not cover.

Pollen is one of the air items the company names, and a symptom is not an endpoint in any named test. A laboratory result on an organism is not a medical conclusion. Certificate 17.0.25812 can be checked at source in OEKO-TEX’s public label check.

Source: C-POLAR — Terms of Use, section 3, https://cpolar.tech/terms/; C-POLAR — Validation, https://cpolar.tech/validation/; NanoFlashing™ Air Filter label; OEKO-TEX Label Check, read 19 September 2026, https://www.oeko-tex.com/en/label-check.

Reviewed on 21 September 2026.